Decitabine, Doxorubicin, and Cyclophosphamide in Treating Children With Relapsed or Refractory Solid Tumors or Neuroblastoma

NCT00075634 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

NIH

Sponsor class

Conditions

Recurrent Neuroblastoma
Unspecified Childhood Solid Tumor, Protocol Specific

Interventions

DRUG: decitabine
DRUG: doxorubicin hydrochloride
DRUG: cyclophosphamide
BIOLOGICAL: filgrastim
BIOLOGICAL: pegfilgrastim
OTHER: laboratory biomarker analysis
OTHER: pharmacological study

Sponsor

National Cancer Institute (NCI)